Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Biodegradable nanoparticles for direct or two-step tumor immunotargeting.

Leila Nobs1, Franz Buchegger, Robert Gurny

  • 1Department of Pharmaceutical Technology and Biopharmaceutics, School of Pharmaceutical Sciences, Ecole de Pharmacie Genève-Lausanne, University of Geneva, Quai Ernest-Ansermet 30, 1211 Geneva 4, Switzerland.

Bioconjugate Chemistry
|January 19, 2006
PubMed
Summary

Biodegradable poly(lactic acid) nanoparticles (NPs) functionalized with antibodies selectively targeted HER2-positive ovarian and CD20-positive lymphoma cancer cells in vitro. Both direct and pretargeting methods demonstrated efficient and specific cancer cell binding, indicating potential as drug carriers.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Protein-based nanocarrier delivering kartogenin derivative to cartilage matrix for intra-articular treatment of osteoarthritis.

Journal of drug delivery science and technology·2026
Same author

Isolation and characterization of two new cytotoxic glycosylsphingolipids from the stem bark of Pithecellobium eriorhachis Harms. (Fabaceae).

Fitoterapia·2026
Same author

Bioanalytical UHPLC-MS/MS Method for Quantification of Terbinafine in Ungual Delivery Studies.

Biomedical chromatography : BMC·2026
Same author

Enzymatically-responsive hyaluronan-glucose hydrogel supports MSC survival and preserves paracrine function under glucose deprivation.

International journal of pharmaceutics·2026
Same author

Cationic liposome-mediated intra-articular delivery of lorecivivint for osteoarthritis treatment.

European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V·2026
Same author

Combining Plant Bioactives With Antibiotics for Enhanced Antibiofilm Activity Against Uropathogenic <i>Staphylococcus</i> spp. and Cytotoxicity Evaluation.

Advances in pharmacological and pharmaceutical sciences·2025

Area of Science:

  • Biomaterials Science
  • Nanotechnology
  • Oncology

Background:

  • Targeted cancer therapy aims to deliver drugs specifically to tumor cells, minimizing off-target effects.
  • Biodegradable nanoparticles offer a promising platform for drug delivery due to their biocompatibility and tunable properties.
  • Antibody-functionalized nanoparticles can enhance specificity by targeting cancer-associated antigens.

Purpose of the Study:

  • To investigate the in vitro targeting efficiency of biodegradable poly(lactic acid) (PLA) nanoparticles (NPs) for selective cancer cell delivery.
  • To compare the efficacy of direct antibody-labeling versus a pretargeting approach for NP-mediated cancer cell targeting.
  • To evaluate the potential of functionalized NPs as drug carriers for tumor-specific delivery.

Main Methods:

Related Experiment Videos

  • Preparation of fluorescent PLA nanoparticles (PB-NPs) and functionalization with thiol groups.
  • Direct targeting: Covalent coupling of anti-HER2 or anti-CD20 monoclonal antibodies (mAbs) to thiolated PB-NPs.
  • Pretargeting: Incubation of cells with biotinylated mAbs followed by NeutrAvidin-Rhodamine Red-X (NAR)-coupled NPs.
  • Flow cytometry analysis to assess specific binding of antibody-conjugated NPs to SKOV-3 (HER2+) and Daudi (CD20+) cancer cells.

Main Results:

  • Anti-HER2-PB-NPs specifically bound to SKOV-3 cells, and anti-CD20-PB-NPs specifically bound to Daudi cells, with a mean signal increase of 10-fold compared to irrelevant IgG-NPs.
  • The pretargeting method showed a 6-fold increase in specific NP binding signal compared to nonspecific binding.
  • Both direct and pretargeting approaches demonstrated efficient and specific binding of functionalized NPs to their respective target cancer cells.

Conclusions:

  • Functionalized PLA nanoparticles can be effectively targeted to specific cancer cells in vitro using both direct antibody conjugation and pretargeting strategies.
  • The developed antibody-coupled or NeutrAvidin-coupled NPs show promise as a drug delivery system for targeted cancer therapy.
  • This study highlights the potential of nanotechnology in developing novel and efficient cancer treatment modalities.